OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease
LONDON and NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO;…
News
OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease
LONDON and NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO;…
Verona Pharma to Report First Quarter 2023 Financial Results and Provide Corporate Update
LONDON and RALEIGH, N.C., April 25, 2023 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Verona Pharma to Report First Quarter 2023 Financial Results and Provide Corporate Update
LONDON and RALEIGH, N.C., April 25, 2023 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Statement re: Further NHS Accreditation
DXS INTERNATIONAL PLC (AQSE: DXSP) Statement Re: Further NHS Accreditation DXS International, the digital clinical…
Statement re: Further NHS Accreditation
DXS INTERNATIONAL PLC (AQSE: DXSP) Statement Re: Further NHS Accreditation DXS International, the digital clinical…
Mithra Releases Invitation to its General Shareholders’ Meeting
Mithra Releases Invitation to its General Shareholders’ Meeting Liege, Belgium, 25 April 2023 – 7:30…
Mithra Releases Invitation to its General Shareholders’ Meeting
Mithra Releases Invitation to its General Shareholders’ Meeting Liege, Belgium, 25 April 2023 – 7:30…
Ultimovacs provides updated guidance on timeline for readout of INITIUM Phase II clinical trial of UV1 in malignant melanoma
It is taking longer than estimated for the patients in the INITIUM study to experience…
Ultimovacs provides updated guidance on timeline for readout of INITIUM Phase II clinical trial of UV1 in malignant melanoma
It is taking longer than estimated for the patients in the INITIUM study to experience…
Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Ad hoc announcement pursuant to Art. 53 LR Q1 sales grew +8% (cc1, +3% USD)…
Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Ad hoc announcement pursuant to Art. 53 LR Q1 sales grew +8% (cc1, +3% USD)…
Idorsia announces financial results for the first quarter 2023 – QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – April 25, 2023 Idorsia…
Idorsia announces financial results for the first quarter 2023 – QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – April 25, 2023 Idorsia…
Vamorolone NDA mid-cycle review meeting by FDA completed
Pratteln, Switzerland, and Rockville, MD, USA, April 25, 2023 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen…
Vamorolone NDA mid-cycle review meeting by FDA completed
Pratteln, Switzerland, and Rockville, MD, USA, April 25, 2023 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen…
CleverTap names Pravin Laghaate as Vice President, Europe, and UK
Mountain View, Calif., London, UK, Amsterdam, Netherlands, & Mumbai, India, Apr 25, 2023 – (ACN…
Cadence Reports First Quarter 2023 Financial Results
SAN JOSE, Calif.–(BUSINESS WIRE)–Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced results for the first…
VNBA joined hands with Tradepass to orchestrate Vietnam’s most disruptive fintech show
HANOI, Vietnam, Apr 25, 2023 – (ACN Newswire) – With a projected value of $18…
Asia EV Technology Summit Thailand 2023
BANGKOK, Apr 25, 2023 – (ACN Newswire) – The emergence of Thailand as the world’s…